Thomas J. Appio is recorded as CEO at Bausch & Lomb Corp (BLCO) since October 12, 2026 and Board Member at Bausch & Lomb Corp (BLCO) since August 5, 2026. Bausch & Lomb Corp reported in an 8-K filed October 13, 2026 that Thomas J. Appio was appointed interim Chief Executive Officer, effective October 12, 2026. Bausch & Lomb Corp reported in an 8-K filed August 6, 2026 that Thomas J. Appio was appointed board of directors, effective August 5, 2026. Thomas J. Appio has spoken on 1 earnings call across 1 company, most recently for Bausch & Lomb Corp on October 28, 2026. Bausch & Lomb Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Bausch & Lomb Corp includes Brent Saunders (Chairman), Thomas W. Ross, Sr. (Chairman and Board Member), Sam Eldessouky (CFO) and 7 others.
“Thomas J. Appio, who is currently Chairman of the Board, was appointed to serve as the interim Chief Executive Officer of the Company, effective as of October 12, 2026.”
Bausch & Lomb Corp Form 8-K, filed October 13, 2026
· Read the filing
“On August 6, 2026, Bausch + Lomb Corporation (the "Company") announced the appointment of Thomas J. Appio, Robert Chersi, Laurence Paul, M.D. and Barbara Trebbi to its board of directors (the "Board"), effective August 5, 2026, to fill the vacancies created by the resignations of Steven H. Collis, Karen L. Ling, Thomas W. Ross, Sr. and Andrew C. von Eschenbach, M.D. (collectively, the "Resigning Directors") from the Board, effective August 5, 2026 .”
Bausch & Lomb Corp Form 8-K, filed August 6, 2026
· Read the filing
Thomas J. Appio on recent calls
“Before we begin, I want to say how honored and energized I am to serve as interim CEO of Bausch & Long. Having spent a good part of my career with the company, I have developed a deep understanding of our business, our markets, our products, and most importantly, the exceptional global team who drive our success.”
